US Stock MarketDetailed Quotes

GPCR Structure Therapeutics

Watchlist
  • 27.900
  • -2.070-6.91%
Close Dec 20 16:00 ET
  • 27.890
  • -0.010-0.04%
Post 20:01 ET
1.60BMarket Cap-14.45P/E (TTM)

Structure Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
4.19%-19.7M
-56.23%-26.39M
-67.82%-34.08M
-72.35%-79.49M
-80.68%-21.73M
-96.14%-20.56M
-67.35%-16.89M
-50.23%-20.31M
-43.41%-46.12M
-11.78%-12.03M
Net income from continuing operations
-42.39%-33.98M
-11.83%-26.03M
-44.85%-26.04M
-74.63%-89.62M
-106.34%-24.5M
-92.17%-23.86M
-66.91%-23.28M
-37.41%-17.98M
-34.88%-51.32M
11.09%-11.88M
Depreciation and amortization
235.44%265K
213.51%232K
217.14%222K
6.50%295K
0.00%72K
3.95%79K
25.42%74K
0.00%70K
284.72%277K
9.09%72K
Other non cash items
-2.54%269K
389.77%431K
421.43%438K
88.76%655K
172.37%207K
196.77%276K
-8.33%88K
2.44%84K
43.98%347K
16.92%76K
Change In working capital
397.75%13.7M
-132.99%-2.03M
-74.82%-8.17M
134.70%6.97M
712.84%2.72M
94.01%2.75M
93.59%6.17M
-292.11%-4.67M
-26.93%2.97M
-129.11%-444K
-Change in prepaid assets
337.44%2.14M
45.30%2.41M
-117.60%-6.63M
-1,223.61%-4.04M
-654.31%-1.75M
-198.15%-900K
285.67%1.66M
-3,039.18%-3.05M
69.74%-305K
-154.95%-232K
-Change in payables and accrued expense
219.43%11.85M
-148.94%-2.21M
17.79%-1.22M
205.98%11.3M
6,789.71%4.55M
413.14%3.71M
11.21%4.52M
-43.91%-1.48M
-30.43%3.69M
-103.97%-68K
-Change in other current assets
--4K
-2,296.30%-1.78M
96.61%-2K
125.00%15K
88.33%-7K
--0
--81K
---59K
-66.67%-60K
---60K
-Change in other current liabilities
-407.02%-289K
-374.74%-451K
-256.52%-328K
12.74%-315K
15.48%-71K
43.00%-57K
7.77%-95K
-24.32%-92K
-76.96%-361K
-33.33%-84K
Cash from discontinued investing activities
Operating cash flow
4.19%-19.7M
-56.23%-26.39M
-67.82%-34.08M
-72.35%-79.49M
-80.68%-21.73M
-96.14%-20.56M
-67.35%-16.89M
-50.23%-20.31M
-43.41%-46.12M
-11.78%-12.03M
Investing cash flow
Cash flow from continuing investing activities
-727.45%-189.04M
-197.65%-204.52M
102.89%1.42M
-332.06%-268.34M
-1,847.84%-180.74M
280.88%30.13M
-327.47%-68.71M
-23.41%-49.02M
-447.77%-62.11M
857.50%10.34M
Net PPE purchase and sale
16.46%-685K
-123.56%-427K
---162K
-1,298.06%-2.17M
-1,528.17%-1.16M
-1,038.89%-820K
-460.38%-191K
--0
87.15%-155K
40.83%-71K
Net investment purchase and sale
-708.61%-188.36M
-197.85%-204.09M
103.22%1.58M
-329.64%-266.18M
-1,824.82%-179.59M
286.61%30.95M
-324.88%-68.52M
-23.61%-49.02M
-424.96%-61.95M
767.67%10.41M
Cash from discontinued investing activities
Investing cash flow
-727.45%-189.04M
-197.65%-204.52M
102.89%1.42M
-332.06%-268.34M
-1,847.84%-180.74M
280.88%30.13M
-327.47%-68.71M
-23.41%-49.02M
-447.77%-62.11M
857.50%10.34M
Financing cash flow
Cash flow from continuing financing activities
-260.04%-757K
173,400.67%514.7M
-99.59%702K
1,456.25%451.53M
89,223.10%281.63M
282.63%473K
-100.96%-297K
11,821.41%169.73M
-71.90%29.01M
-174.78%-316K
Net common stock issuance
--0
--514.57M
--0
--472.3M
--300M
--0
--0
--172.3M
--0
--0
Net preferred stock issuance
----
----
----
--0
----
----
----
----
-69.52%31.5M
--0
Proceeds from stock option exercised by employees
-16.07%397K
301.68%719K
2,335.48%755K
2,324.24%800K
--117K
1,531.03%473K
4,375.00%179K
--31K
200.00%33K
--0
Net other financing activities
---1.15M
-23.74%-589K
97.96%-53K
-756.09%-21.57M
-5,750.63%-18.49M
--0
-1.93%-476K
-79.63%-2.6M
-2,090.43%-2.52M
---316K
Cash from discontinued financing activities
Financing cash flow
-260.04%-757K
173,400.67%514.7M
-99.59%702K
1,456.25%451.53M
89,223.10%281.63M
282.63%473K
-100.96%-297K
11,821.41%169.73M
-71.90%29.01M
-174.78%-316K
Net cash flow
Beginning cash position
840.18%381.63M
-22.66%97.83M
397.46%129.79M
-75.22%26.09M
80.25%50.64M
-26.85%40.59M
149.88%126.49M
-75.22%26.09M
543.99%105.31M
-75.59%28.09M
Current changes in cash
-2,185.58%-209.5M
430.37%283.8M
-131.83%-31.96M
230.91%103.7M
4,055.82%79.16M
136.66%10.05M
-1,864.63%-85.9M
283.60%100.4M
-189.05%-79.21M
79.57%-2M
End cash Position
239.94%172.13M
840.18%381.63M
-22.66%97.83M
397.46%129.79M
397.46%129.79M
80.25%50.64M
-26.85%40.59M
149.88%126.49M
-75.22%26.09M
-75.22%26.09M
Free cash flow
4.66%-20.38M
-56.98%-26.82M
-68.61%-34.24M
-76.46%-81.66M
-89.18%-22.89M
-102.57%-21.38M
-70.14%-17.09M
-49.51%-20.31M
-38.69%-46.28M
-11.20%-12.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 4.19%-19.7M-56.23%-26.39M-67.82%-34.08M-72.35%-79.49M-80.68%-21.73M-96.14%-20.56M-67.35%-16.89M-50.23%-20.31M-43.41%-46.12M-11.78%-12.03M
Net income from continuing operations -42.39%-33.98M-11.83%-26.03M-44.85%-26.04M-74.63%-89.62M-106.34%-24.5M-92.17%-23.86M-66.91%-23.28M-37.41%-17.98M-34.88%-51.32M11.09%-11.88M
Depreciation and amortization 235.44%265K213.51%232K217.14%222K6.50%295K0.00%72K3.95%79K25.42%74K0.00%70K284.72%277K9.09%72K
Other non cash items -2.54%269K389.77%431K421.43%438K88.76%655K172.37%207K196.77%276K-8.33%88K2.44%84K43.98%347K16.92%76K
Change In working capital 397.75%13.7M-132.99%-2.03M-74.82%-8.17M134.70%6.97M712.84%2.72M94.01%2.75M93.59%6.17M-292.11%-4.67M-26.93%2.97M-129.11%-444K
-Change in prepaid assets 337.44%2.14M45.30%2.41M-117.60%-6.63M-1,223.61%-4.04M-654.31%-1.75M-198.15%-900K285.67%1.66M-3,039.18%-3.05M69.74%-305K-154.95%-232K
-Change in payables and accrued expense 219.43%11.85M-148.94%-2.21M17.79%-1.22M205.98%11.3M6,789.71%4.55M413.14%3.71M11.21%4.52M-43.91%-1.48M-30.43%3.69M-103.97%-68K
-Change in other current assets --4K-2,296.30%-1.78M96.61%-2K125.00%15K88.33%-7K--0--81K---59K-66.67%-60K---60K
-Change in other current liabilities -407.02%-289K-374.74%-451K-256.52%-328K12.74%-315K15.48%-71K43.00%-57K7.77%-95K-24.32%-92K-76.96%-361K-33.33%-84K
Cash from discontinued investing activities
Operating cash flow 4.19%-19.7M-56.23%-26.39M-67.82%-34.08M-72.35%-79.49M-80.68%-21.73M-96.14%-20.56M-67.35%-16.89M-50.23%-20.31M-43.41%-46.12M-11.78%-12.03M
Investing cash flow
Cash flow from continuing investing activities -727.45%-189.04M-197.65%-204.52M102.89%1.42M-332.06%-268.34M-1,847.84%-180.74M280.88%30.13M-327.47%-68.71M-23.41%-49.02M-447.77%-62.11M857.50%10.34M
Net PPE purchase and sale 16.46%-685K-123.56%-427K---162K-1,298.06%-2.17M-1,528.17%-1.16M-1,038.89%-820K-460.38%-191K--087.15%-155K40.83%-71K
Net investment purchase and sale -708.61%-188.36M-197.85%-204.09M103.22%1.58M-329.64%-266.18M-1,824.82%-179.59M286.61%30.95M-324.88%-68.52M-23.61%-49.02M-424.96%-61.95M767.67%10.41M
Cash from discontinued investing activities
Investing cash flow -727.45%-189.04M-197.65%-204.52M102.89%1.42M-332.06%-268.34M-1,847.84%-180.74M280.88%30.13M-327.47%-68.71M-23.41%-49.02M-447.77%-62.11M857.50%10.34M
Financing cash flow
Cash flow from continuing financing activities -260.04%-757K173,400.67%514.7M-99.59%702K1,456.25%451.53M89,223.10%281.63M282.63%473K-100.96%-297K11,821.41%169.73M-71.90%29.01M-174.78%-316K
Net common stock issuance --0--514.57M--0--472.3M--300M--0--0--172.3M--0--0
Net preferred stock issuance --------------0-----------------69.52%31.5M--0
Proceeds from stock option exercised by employees -16.07%397K301.68%719K2,335.48%755K2,324.24%800K--117K1,531.03%473K4,375.00%179K--31K200.00%33K--0
Net other financing activities ---1.15M-23.74%-589K97.96%-53K-756.09%-21.57M-5,750.63%-18.49M--0-1.93%-476K-79.63%-2.6M-2,090.43%-2.52M---316K
Cash from discontinued financing activities
Financing cash flow -260.04%-757K173,400.67%514.7M-99.59%702K1,456.25%451.53M89,223.10%281.63M282.63%473K-100.96%-297K11,821.41%169.73M-71.90%29.01M-174.78%-316K
Net cash flow
Beginning cash position 840.18%381.63M-22.66%97.83M397.46%129.79M-75.22%26.09M80.25%50.64M-26.85%40.59M149.88%126.49M-75.22%26.09M543.99%105.31M-75.59%28.09M
Current changes in cash -2,185.58%-209.5M430.37%283.8M-131.83%-31.96M230.91%103.7M4,055.82%79.16M136.66%10.05M-1,864.63%-85.9M283.60%100.4M-189.05%-79.21M79.57%-2M
End cash Position 239.94%172.13M840.18%381.63M-22.66%97.83M397.46%129.79M397.46%129.79M80.25%50.64M-26.85%40.59M149.88%126.49M-75.22%26.09M-75.22%26.09M
Free cash flow 4.66%-20.38M-56.98%-26.82M-68.61%-34.24M-76.46%-81.66M-89.18%-22.89M-102.57%-21.38M-70.14%-17.09M-49.51%-20.31M-38.69%-46.28M-11.20%-12.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Micron Technology
MU
+3.48%
NVIDIA
NVDA
+3.08%
Intel
INTC
+2.41%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%

Unlock the Full List

Investment Theme Weight Loss Drugs
Weight Loss Drugs
Intraday-4.61%